All members have the option of attending our various HTC-centric events which include:
Date: February 26 - 28, 2025 Location: Austin, TX Please contact Jeff Amond with any questions regarding this registration at amond@hemoalliance.org or 608-206-3132.
Date: March 9 - 11, 2025 Location: Salt Lake City, Utah Please contact Theresa Parker with any questions regarding this registration at theresa@hemoalliance.org or 727-688-2568.
Date: Wednesday, March 19th, 2025 Time: 12:00pm - 1:00pm ET WEBINAR TOPIC: Updates from Washington: Administration and Congressional Actions OBJECTIVE: The current status of government funding for fiscal year 2025. The potential impact of the new Administration’s early actions, including Executive Orders, reduction in agency staffing, changes to the regulatory process and how this may Read the full article...
Date: Thursday, March 20th, 2025 Time: 2:00pm - 3:00pm ET TITLE: Takeda FVIII Portfolio OBJECTIVE: Please join Takeda leadership to review Takeda FVIII Products & Resources Available. INTENDED AUDIENCE: All HTC staff SPEAKER: Anthea Cherednichenko, VP US Hematology Franchise Head Anthea leads the sales and marketing teams for Takeda’s Hematology portfolio. Anthea Read the full article...
Date: Thursday, April 3rd, 2025 Time: 2:00pm - 3:00pm ET WEBINAR TOPIC: Alhemo (concizumab-mtci): A new option for patients living with hemophilia A or B with inhibitors OBJECTIVE: To provide a prescribing information overview of the recently FDA approved medication, Alhemo (concizumab-mtci), for patients living with hemophilia A or B with Read the full article...
